Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Roila

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2010
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)Fausto Roila, David Warr, Matti Aapro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2005
Evidence-based recommendations for the use of antiemetics in radiotherapyErnesto Maranzano, Petra Ch Feyer, Alexander Molassiotis, et al.
Tumori|March 10, 2010
Surgical treatment of primitive thyroid lymphomaNicola Avenia, Mark Ragusa, Roberto Cirocchi, et al.
BMJ Open|July 2, 2018
Conflict of interest among Italian medical oncologists: a national surveyAndrea DeCensi, Gianmauro Numico, Enzo Ballatori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2006
The impact of chemotherapy-induced nausea and vomiting on health-related quality of lifeEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Oncology and Therapy|January 23, 2022
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the LiteratureSara Baglivo, Martina Mandarano, Guido Bellezza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research GroupRossana De Palma, Alessandro Liberati, Giovannino Ciccone, et al.
Human Vaccines & Immunotherapeutics|May 18, 2021
Immune checkpoint inhibitors for unresectable malignant pleural mesotheliomaGiulio Metro, Diego Signorelli, Elio G Pizzutilo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2006
The cost of chemotherapy-induced nausea and vomiting in ItalyEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Journal of Chemotherapy (Florence, Italy)|December 20, 2022
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two casesGiulio Metro, Sara Baglivo, Niccolò Metelli, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2010
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)Fausto Roila, David Warr, Matti Aapro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2005
Evidence-based recommendations for the use of antiemetics in radiotherapyErnesto Maranzano, Petra Ch Feyer, Alexander Molassiotis, et al.
Tumori|March 10, 2010
Surgical treatment of primitive thyroid lymphomaNicola Avenia, Mark Ragusa, Roberto Cirocchi, et al.
BMJ Open|July 2, 2018
Conflict of interest among Italian medical oncologists: a national surveyAndrea DeCensi, Gianmauro Numico, Enzo Ballatori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2006
The impact of chemotherapy-induced nausea and vomiting on health-related quality of lifeEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Oncology and Therapy|January 23, 2022
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the LiteratureSara Baglivo, Martina Mandarano, Guido Bellezza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research GroupRossana De Palma, Alessandro Liberati, Giovannino Ciccone, et al.
Human Vaccines & Immunotherapeutics|May 18, 2021
Immune checkpoint inhibitors for unresectable malignant pleural mesotheliomaGiulio Metro, Diego Signorelli, Elio G Pizzutilo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2006
The cost of chemotherapy-induced nausea and vomiting in ItalyEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Journal of Chemotherapy (Florence, Italy)|December 20, 2022
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two casesGiulio Metro, Sara Baglivo, Niccolò Metelli, et al.
Pageof 10